| dc.description.abstract | The world death rate due to smoking has reached more than 5.1 million people per year. World Health Organization (WHO) estimates that in 2020, the world population death rate due to smoking will reach 7.5 million people per year. The prevalence of lung disease including obstruction and restriction related to smoking habit is approximately 42%. This lung disease resulted in breathlessness and oxygenation degression. Provison of oxygenated water will provide extra oxygen shown by elevation of blood oxygen saturation (SaO2). Absorbed oxygen will be utilized in lipid metabolism. The objectives of this research were to evaluate the provision of oxygenated water to blood oxygen saturation and blood lipid profile in patients with lung disease. Provision of oxygenated water was conducted in two phases, short-term and long-term. Short-term test was conducted by measuring SaO2 after drinking oxygenated water on 0, 1, 5, and 10 minutes interval, meanwhile long-term test conducted for 21 days was observed by measuring the changes of blood lipid profile. Short-term test showed that there was tendency of SaO2 elevation after consuming oxygenated water. Concentration of 50 ppm oxygenated water was able to increase blood SaO2. Long-term test showed that the drinking of oxygenated water (100 ppm) for 21 days by 16 respondents : 13 lung disease respondents and 3 normal respondents did not give significant changes of blood lipid at 5% significance level, but there was tendency to repair blood lipid profile. Subjective response result showed that lung disease patients were feeling better after drinking 100 ppm oxygenated water everyday for 21 days. | en |
